IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies

Pulmonary Pharmacology & Therapeutics
Giovanni PassalacquaGiorgio Walter Canonica

Abstract

The recent advances in the knowledge of immunological aspects of many pulmonary diseases, allowed to identify cells, biological functions, cytokines, and receptors that are preferentially involved in each disease. This is the case of asthma, where IL-13 (together with IL-4) is recognized as a central mediator. The role of IL-13 is strictly related, via complex signaling pathways, to eosinophil recruitment and activation, to mucus secretion, periostin generation and to fibrogenic processes (which are part of the remodeling process). These peculiar roles of IL-13 have suggested the hypothesis of its role in Idiopathic Pulmonary Fibrosis, and consequently of its antagonists in the treatment of such disease. We review herein the immunological roles of IL-13 in asthma and IPF, and the currently ongoing attempts to treat IPF by IL-13 antagonism strategies.

Citations

May 8, 2018·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Danielle Karo-AtarAriel Munitz
Sep 18, 2017·Cellular and Molecular Life Sciences : CMLS·David N O'Dwyer, Bethany B Moore
Aug 5, 2018·The Journal of Biological Chemistry·Yasutaka MitamuraKenji Izuhara
Jan 12, 2019·Expert Opinion on Drug Metabolism & Toxicology·Diego BagnascoGiorgio Walter Canonica
Jan 5, 2020·Expert Review of Respiratory Medicine·Diego BagnascoGiorgio Walter Canonica
Apr 17, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eva SchrufJames P Garnett
Jan 17, 2020·JCI Insight·Kristen M GlisinskiChristina E Barkauskas
Feb 1, 2019·American Journal of Respiratory Cell and Molecular Biology·Sathisha Upparahalli VenkateshaiahAnil Mishra
Sep 18, 2020·International Journal of Molecular Sciences·Shuichi MatsudaYoshitoshi Kasuya
Oct 31, 2020·Scientific Reports·Caroline Busatta Vaz de PaulaLucia de Noronha
Feb 16, 2021·International Immunopharmacology·Bruno Marques VieiraPedro Xavier Elsas
May 1, 2021·International Journal of Molecular Sciences·Jana Adamcakova, Daniela Mokra
Mar 23, 2021·Rejuvenation Research·Giovanna Elisiana CarpagnanoDonato Lacedonia
Jul 9, 2021·Frontiers in Cell and Developmental Biology·Chris M Li, Zhibin Chen
Jul 3, 2021·International Journal of Molecular Sciences·Paula MonteroJulio Cortijo
Jul 15, 2021·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Siavash BolouraniPing Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

American Journal of Respiratory and Critical Care Medicine
Kenji IzuharaJoseph R Arron
Clinical Pharmacology and Therapeutics
G GeorgeR Summer
© 2022 Meta ULC. All rights reserved